Showing results (1-10 of 152) with videos related to
Sort By:
Pageof 16
Bioanalysis|June 21, 2018
Biomarkers in early-phase trials: fundamental issuesLaura M Yee, Tracy G Lively, Lisa M McShaneCancer Journal (Sudbury, Mass.)|July 24, 2019
Biostatistical and Logistical Considerations in the Development of Basket and Umbrella Clinical TrialsLaura M Yee, Lisa M McShane, Boris Freidlin, et al.The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics|September 28, 2019
Biomarker Validation: Context and ComplexitiesLisa M McShaneBMC Medicine|May 31, 2012
Statistical challenges in the development and evaluation of marker-based clinical testsLisa M McShaneAmerican Journal of Pharmacogenomics : Genomics-Related Research in Drug Development and Clinical Practice|December 13, 2005
Cancer diagnostics: decision criteria for marker utilization in the clinicSheila E Taube, James W Jacobson, Tracy G LivelyJournal of Biopharmaceutical Statistics|August 26, 2016
Issues in developing multivariable molecular signatures for guiding clinical care decisionsMichael C Sachs, Lisa M McShaneStatistics in Medicine|May 1, 2022
Sample size methods for evaluation of predictive biomarkersKevin K Dobbin, Lisa M McShaneJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 17, 2012
Publication of tumor marker research results: the necessity for complete and transparent reportingLisa M McShane, Daniel F HayesMolecular Oncology|November 10, 2020
Molecular genomic features associated with in vitro response of the NCI-60 cancer cell line panel to natural productsJulia Krushkal, Simarjeet Negi, Laura M Yee, et al.Clinical Trials (London, England)|September 4, 2013
Development of omics-based clinical tests for prognosis and therapy selection: the challenge of achieving statistical robustness and clinical utilityLisa M McShane, Mei-Yin C PolleyPageof 16